Pharmacological significance of triazole scaffold
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2010/06/28
-
Indian UGC (journal)
-
Refrences157
-
Citations406
-
Rajeev Kharb Sanjivani College of Pharmaceutical Sciences, Khetri, India
-
Prabodh Chander Sharma Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, India
-
Mohammed Shahar Yar Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
Cite
Kharb, Rajeev, et al. “Pharmacological Significance of Triazole Scaffold”. Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 26, no. 1, 2010, pp. 1-21, https://doi.org/10.3109/14756360903524304.
Kharb, R., Sharma, P. C., & Yar, M. S. (2010). Pharmacological significance of triazole scaffold. Journal of Enzyme Inhibition and Medicinal Chemistry, 26(1), 1-21. https://doi.org/10.3109/14756360903524304
Kharb R, Sharma PC, Yar MS. Pharmacological significance of triazole scaffold. Journal of Enzyme Inhibition and Medicinal Chemistry. 2010;26(1):1-21.
Journal Categories
Medicine
Therapeutics
Pharmacology
Science
Biology (General)
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Non Platinum Metal Complexes as Anti‐cancer Drugs
- Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials
- Ueber ein Kondensationsprodukt aus Formaldehyd, Ammoniak und Antipyrin
- Cisplatin: The first metal based anticancer drug
- Medicinal attributes of 1,2,3-triazoles: Current developments
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Design, Synthesis, and Evaluation of Novel Fluoroquinolone−Aminoglycoside Hybrid Antibiotics | Journal of Medicinal Chemistry |
| 108 | 2009 |
| 10.1200/JCO.2008.18.4127 | 2009 | |||
The Immunosuppressor ST1959, a 3,5-Diaryl-S-Triazole Derivative, Inhibits T Cell Activation by Reducing NFAT Nuclear Residency | International Journal of Immunopathology and Pharmacology |
| 9 | 2009 |
| Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives | Acta Pharmaceutica |
| 49 | 2008 |
| Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines | Acta Pharmaceutica |
| 79 | 2008 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies | Archiv der Pharmazie |
| 1 | 2024 |
Halo‐1,2,3‐triazoles: Valuable Compounds to Access Biologically Relevant Molecules | ChemBioChem |
| 1 | 2024 |
Synthesis and Anticancer Evaluation of Lawsone bound triazoles | ChemistrySelect |
| 2024 | |
| Synthesis of novel GABA-Triazole tethered derivatives of Noscapine and their anticancer activities | Monatshefte für Chemie - Chemical Monthly |
| 2024 | |
| Experimental investigation of the effect of tebuconazole on three biomarkers of innate immunity in the house sparrow (Passer domesticus) | Ecotoxicology |
| 2024 |
Citations Analysis
The category
Science: Chemistry 268
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Synthetic utility of sydnones: synthesis of pyrazolines derivatized with 1,2,4-triazoles as antihyperglymic, antioxidant agents and their DNA cleavage study and was published in 2011. The most recent citation comes from a 2024 study titled Virtual Screening of a Chemically Diverse “Superscaffold” Library Enables Ligand Discovery for a Key GPCR Target. This article reached its peak citation in 2021, with 73 citations. It has been cited in 175 different journals, 16% of which are open access. Among related journals, the ChemistrySelect cited this research the most, with 17 citations. The chart below illustrates the annual citation trends for this article.